Inventor · disambiguated record
Wenxin Xu
Also filed as: XU WENXIN
20 granted patents·12 pending applications·246 citations·filing 1993–2025
95Inventor score
Files withALTOR BIOSCIENCE LLC18ALTOR BIOSCIENCE CORP3BETTA PHARMACEUTICALS CO LTD2ILLINOIS TECHNOLOGY INST2HANGZHOU VIROMAB BIOTECH CO LTD1
Top patents by PatentIndex Score
32 records- 0198US11992516B2Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodiesALTOR BIOSCIENCE LLC·Filed 2022·Granted May 28, 2024·3 cites·10 claims
- 0298US11925676B2Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complexALTOR BIOSCIENCE LLC·Filed 2023·Granted Mar 12, 2024·3 cites·23 claims
- 0398US11890323B2Method of treating cancer with composition comprising IL-15-based molecules and BCGALTOR BIOSCIENCE LLC·Filed 2022·Granted Feb 6, 2024·3 cites·6 claims
- 0498US11679144B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 20, 2023·6 cites·9 claims
- 0598US11471511B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Granted Oct 18, 2022·13 cites·7 claims
- 0698US11173191B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 16, 2021·13 cites·8 claims
- 0798US10537615B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 21, 2020·23 cites·7 claims
- 0898US9925247B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2015·Granted Mar 27, 2018·37 cites·25 claims
- 0997US11369679B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 28, 2022·10 cites·16 claims
- 1097US11318201B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2021·Granted May 3, 2022·13 cites·9 claims
- 1193US12318432B2BCG and IL-15 based moleculesALTOR BIOSCIENCE LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 1293US12268732B2IL-15-based molecules with anti-CD20 antibody and methods of useALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·5 claims
- 1393US12268731B2Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)ALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·11 claims
- 1493US2024299498A1Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complexALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1592US12097244B2Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibodyALTOR BIOSCIENCE LLC·Filed 2023·Granted Sep 24, 2024·0 cites·23 claims
- 1692US11886967B1Long-term streamflow forecast method and system based on process-data synergic driveUNIV WUHAN·Filed 2023·Granted Jan 30, 2024·19 cites·8 claims
- 1790US11229668B2Maximizing T-cell memory and compositions and methods thereforNANTCELL INC·Filed 2018·Granted Jan 25, 2022·3 cites·20 claims
- 1889US12186372B2IL-15-based molecules and methods of treating a neoplasiaALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 7, 2025·0 cites·21 claims
- 1987US2025262277A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 2087US2025262278A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 2178US5390181AMethod for detecting collisions on and controlling access to a transmission channelILLINOIS TECHNOLOGY INST·Filed 1993·Granted Feb 14, 1995·78 cites·17 claims
- 2268US12491201B2Maximizing T-cell memory and compositions and methods thereforNantCell·Filed 2021·Granted Dec 9, 2025·0 cites·18 claims
- 2358US2018200366A1Multimeric il-15-based moleculesALTOR BIOSCIENCE CORP·Filed 2017·Application pending·0 cites
- 2458US2025304690A1Therapeutic agent comprising multispecific antibody and use thereof in tumor therapyHANGZHOU VIROMAB BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 2556US2025104366A1Selective Boundaries for an Application Executing in an Artificial Reality EnvironmentMETA PLATFORMS TECH LLC·Filed 2024·Application pending·0 cites
- 2654US2024327518A1Anti-pd-l1 nanobody and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2753US2024383974A1Bispecific antibody and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2852US2020407862A1Electrolytic cell cathode with zero polar spacingJIANGSU ANCAN TECH CO LTD·Filed 2019·Application pending·0 cites
- 2950US2019328838A1Compositions comprising il-2 fusion proteins and methods for treating neoplasiaALTOR BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 3049US6292493B1Method and apparatus for detecting collisions on and controlling access to a transmission channelILLINOIS TECHNOLOGY INST·Filed 1997·Granted Sep 18, 2001·22 cites·7 claims
- 3147US2015216937A1Methods for treating neoplasiaALTOR BIOSCIENCE CORP·Filed 2013·Application pending·0 cites
- 3246US2015285194A1Energy-Saving and Emission-Reducing Apparatus for Disturbing and Boosting Mixture Gas of Fuel Oil EngineXU WENXIN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenxin Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →